Cargando…
Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial
BACKGROUND: The risk/benefit ratio of using statins for primary prevention of cardiovascular (CV) events in elderly people has not been established. The main objectives of the present study are to assess the cost-effectiveness of statin cessation and to examine the non-inferiority of statin cessatio...
Autores principales: | Bonnet, Fabrice, Bénard, Antoine, Poulizac, Pierre, Afonso, Mélanie, Maillard, Aline, Salvo, Francesco, Berdaï, Driss, Salles, Nathalie, Rousselot, Nicolas, Marchi, Sébastien, Hayes, Nathalie, Joseph, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169009/ https://www.ncbi.nlm.nih.gov/pubmed/32307005 http://dx.doi.org/10.1186/s13063-020-04259-5 |
Ejemplares similares
-
A new approach for sample size calculation in cost-effectiveness studies based on value of information
por: Bader, Clément, et al.
Publicado: (2018) -
A multistate transition model for statin‐induced myopathy and statin discontinuation
por: Zhu, Yuxi, et al.
Publicado: (2021) -
Time to define common European criteria for therapeutic added value
por: Boucaud-Maitre, Denis, et al.
Publicado: (2022) -
Statin discontinuation: counterbalancing the benefits with the potential risks
por: Paraskevas, Kosmas I., et al.
Publicado: (2011) -
Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)